Your Messages Inbox
Your Article Summary
See Latest ArticlesAbbott and AstraZeneca Extend Relationship to Include Co-promotion of TRILIPIX (fenofibric acid)
Abbott, 06/05/09
Abbott and AstraZeneca announced that they have entered into an agreement for AstraZeneca to co-promote Abbott's TRILIPIX, a medication for use alone or in combination with a statin to treat certain lipid disorders. Under the terms of the agreement, AstraZeneca will obtain the non-exclusive right to co-promote TRILIPIX alongside Abbott in the United States, excluding Puerto Rico.
Today in M&A/Partnerships...keeping you current
Receive free subspecialty "5-minute updates" via email
GSK completes extension of strategic collaboration with Aspen
GlaxoSmithKline, 12/02/09
Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
Novartis, 11/25/09
Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread(R) for Chronic Hepatitis B in Key Asian Countries
Gilead, 11/25/09
Article Search
Sponsor